GCKR and GCK polymorphisms are associated with increased risk of end-stage kidney disease in Chinese patients with type 2 diabetes: The Hong Kong Diabetes Register (1995–2019)
- Resource Type
- Article
- Source
- In
Diabetes Research and Clinical Practice November 2022 193 - Subject
- Language
- ISSN
- 0168-8227